Mark S. Ordan received $14.1M in total compensation as Chief Executive Officer of Pediatrix Medical Group, Inc. in FY2025. The largest component was $8.5M in stock awards. Source: SEC DEF 14A.
In fiscal year 2025, Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group, Inc. (MD), received total compensation of $14.1 million.
Mark S. Ordan's compensation breakdown includes: base salary of $970K, bonus of $2 million, stock awards valued at $8.5 million, non-equity incentive compensation of $2.7 million, and other compensation of $14K.
Pediatrix Medical Group, Inc.'s top 5 named executive officers received combined total compensation of $27.1 million in fiscal year 2025.
The named executive officers disclosed in Pediatrix Medical Group, Inc.'s 2025 proxy statement are:Mark S. Ordan (Chief Executive Officer) with total compensation of $14.1 million, James D. Swift (Former Chief Executive Officer) with total compensation of $2.8 million, Don Gregory Neeb (Executive Vice President Chief Investment & Strategy Officer) with total compensation of $5.3 million, Mary Ann E. Moore (Executive Vice President General Counsel Chief Administrative Officer and Secretary) with total compensation of $3.0 million, and Kasandra H. Rossi (Executive Vice President Chief Financial Officer & Treasurer) with total compensation of $1.9 million.
Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group, Inc. (MD), received $14,140,217 in total compensation for FY2025. Stock awards of $8,456,024 were the largest component. Figures come from Pediatrix Medical Group, Inc.'s DEF 14A 0001193125-26-127299 filed 27 Mar 2026.
Source Filing
Executive Record
Mark S. Ordan
Chief Executive Officer
Reported Pay
$14.1MSummary compensation table total · FY2025
Read the board's pay decision against shareholder returns and current filing context.
Pediatrix Medical Group, Inc. (MD) — Key Facts
Last updated Sep 19, 2026 · DEF 14A filed Mar 27, 2026
| CEO | Mark S. Ordan, Chief Executive Officer |
|---|---|
| Fiscal year | FY2025 |
| Total compensation | $14.1M |
| Base salary | $970K |
| Stock awards | $8.5M |
| Other compensation | $14K |
| Source | DEF 14A, 2026-03-27 |
Mark S. Ordan, the Chief Executive Officer of Pediatrix Medical Group, Inc., received total compensation of $14,140,217 in fiscal year 2025. This includes base salary of $970,014 and stock awards valued at $8,456,024. Figures come from Pediatrix Medical Group, Inc.'s DEF 14A 0001193125-26-127299 filed 27 Mar 2026.
Mark S. Ordan's base salary at Pediatrix Medical Group, Inc. is $970,014 per year as of fiscal year 2025. However, total compensation including stock awards, bonuses, and other benefits is $14,140,217. Figures come from Pediatrix Medical Group, Inc.'s DEF 14A 0001193125-26-127299 filed 27 Mar 2026.
Pediatrix Medical Group, Inc.'s CEO, Mark S. Ordan, earned $14,140,217 in total compensation for fiscal year 2025. The majority of this compensation comes from stock awards ($8,456,024) rather than base salary ($970,014). Figures come from Pediatrix Medical Group, Inc.'s DEF 14A 0001193125-26-127299 filed 27 Mar 2026.
Reading filings for MD...
Reading the latest proxy statement
Calculating CEO-to-worker ratio
Checking insider sales and trading plans